Linked Life Data

17878804

Source:http://linkedlifedata.com/resource/pubmed/id/17878804

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
8-9
pubmed:dateCreated
2007-9-19
pubmed:abstractText
Corticobasal degeneration (CBD) is a neurodegenerative disorder of mid- to late-adult life. From a clinical standpoint, CBD is characterized by (i) an insidious onset and a slowly progressing, unilateral, levodopa-unresponsive parkinsonian syndrome with dystonia or myoclonus and (ii) cerebral features such as apraxia, alien limb phenomena and cortical sensory loss. Decisive clinical diagnostic criteria are not available and thus a neuropathological study remains essential for accurate CBD diagnosis. Consequently, additional non-clinical criteria must be identified in order to improve diagnosis while patients are still alive.
pubmed:language
fre
pubmed:journal
pubmed:citationSubset
IM
pubmed:status
MEDLINE
pubmed:month
Sep
pubmed:issn
0035-3787
pubmed:author
pubmed:issnType
Print
pubmed:volume
163
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
779-91
pubmed:meshHeading
pubmed:year
2007
pubmed:articleTitle
[Neurophysiology of corticobasal degeneration].
pubmed:affiliation
Service de Neurophysiologie Clinique, EA 2683, IFR 114, Hôpital Roger Salengro, 59037 Lille Cedex.
pubmed:publicationType
Journal Article, English Abstract, Review